Evidence map›Paper›PMID 41611449›Full record

ArticleLife science alliance2026

Repeated proliferative events ameliorate age-associated accumulation of DNA damage in HSPCs.

Shubham Haribhau Mehatre, Harsh Agrawal, Irene Mariam Roy, Sarah Schouteden, Satish Khurana

Abstract read
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shubham Haribhau MehatreSchool of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India.ORCID 0000-0003-4869-848X
Harsh AgrawalSchool of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India.
Irene Mariam RoySchool of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India.
Sarah SchoutedenInter-departmental Stem Cell Institute, KU Leuven, Leuven, Belgium.
Satish KhuranaSchool of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India satishkhurana@iisertvm.ac.in.ORCID 0000-0001-5176-1510

Funding

Wellcome Trust
6 · The paper itself

Abstract

Upon aging, hematopoietic stem cells show accumulation of DNA damage that has been causally linked with their functional decline, with debatable role of proliferative events. In this study, we sought to enquire the effect of increased proliferation rate in hematopoietic stem and progenitor cells (HSPCs) on hematopoietic aging. Multiple rounds of blood withdrawals were performed during adult life to maintain a higher proliferation rate in HSPC population in mice. Our experiments showed little effect of increased proliferation on age-associated functional decline in the hematopoietic system. However, we noted a decrease in the double-strand breaks accumulated with age after the serial bleeding regimen. Analysis of scRNA-Seq data from mouse and human HSPCs showed enrichment of DNA damage response pathways. Importantly, we demonstrate that the induction of HSPC proliferation in aged mice was sufficient to activate the DNA damage response in vivo and decrease the load of double-strand breaks. Hence, these results show that repeated blood withdrawals equivalent to clinical blood donation clear DNA damages without impacting the functioning of HSPCs.

Indexed as

AgingCell ProliferationDNA DamageHematopoietic Stem CellsAnimalsDNA Breaks, Double-StrandedDNA RepairHumansMaleMiceMice, Inbred C57BL

Identifiers

PMID41611449
PMCPMC12861689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.